How to export packaged medicines to Saudi Arabia? GTİP code, documents, customs duty and buyers
Imports of heading 3004 from Türkiye into Saudi Arabia came to US$11.4m in the last 12 months (May 2025–April 2026): 0.3% of its imports. Against the 12 months before: +21.8%.
Figures are for heading 3004: the official statistics go no deeper. Each figure has its source and date beside it.
Imports from Türkiye into Saudi Arabia
Heading 3004 · May 2025 – April 2026
US$11.4m+21.8% on the 12 months before
The 12 months before: US$9.32m
- From Türkiye
- Other origins
Reported by Saudi Arabia, from its own import statistics.
UN Comtrade (United Nations Statistics Division)
Dataset UN Comtrade C/M/HS(opens in a new tab)Updated at the source on 30 July 2026.
The customs watch computed these figures on 2 November 2026.
The market in Saudi Arabia
The market's own import figures for heading 3004, last 12 months.
- Imports from the world, 12 months
- US$4.4bn-22.4% on the 12 months before
- Türkiye's share
- 0.3%0.2% in the 12 months before
The largest suppliers
| Origin | 12 months | Share |
|---|---|---|
| US$584m | 13.3% | |
| US$536m | 12.2% | |
| US$373m | 8.5% | |
| US$359m | 8.2% | |
| US$321m | 7.3% |
Customs duty
0%on the CIF value
The market's general (MFN) rateFrom the WTO's tariff data (its Integrated Data Base), WTO 2025, HS 2022No free trade agreement; Türkiye–GCC talks under wayMinistry of Trade, checked 2 November 2026(opens in a new tab)The rate set for HS 3004.90checked on 2 November 2026Official source(opens in a new tab)
The code
HS subheading (6 digits), the same in every country
GTİP 3004.90
Medicaments; consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
Official Turkish title: Tedavide veya korunmada kullanılmak üzere karışık olan veya karışık olmayan diğer ilaçlar; dozlandırılmış veya perakende satış için ambalajlanmış
Heading 3004Medicaments; (not goods of heading no. 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic use, put up in measured doses (incl. those in the form of transdermal admin. systems) or packed for retail sale
Türkiye exported €1.02bn of HS 3004.90 in 2025: rank 20 of 5,132 subheadings.
Source: Eurostat, Comext DS-059341 (the figures Türkiye declared). The ranking is calculated by Birlesa from Eurostat's figures; Eurostat bears no responsibility for it.
3 national tariff lines (12 digits)
Declarations in Türkiye use one of these lines; each has its own page.
- 3004.90.00.00.11Onkolojik ilaçlar; dozlandırılmış veya perakende satış için ambalajlanmış
- 3004.90.00.00.12Hematolojik ilaçlar; dozlandırılmış veya perakende satış için ambalajlanmış
- 3004.90.00.00.19Tedavide veya korunmada kullanılmak üzere karışık olan veya karışık olmayan diğer ilaçlar; dozlandırılmış veya perakende satış için ambalajlanmış
Its page in the codes guideTÜİK Sınıflama Sunucusu: GTİP 2026(opens in a new tab)UN Statistics Division: HS 2022 (H6)(opens in a new tab)
Frequently asked questions
- What import duty does Saudi Arabia charge on packaged medicines?
- Saudi Arabia charges 0% on packaged medicines of Turkish origin (on the CIF value). The rate was checked at its source on 2 November 2026.
- Where does Türkiye rank among Saudi Arabia's suppliers of packaged medicines?
- From May 2025 to April 2026, Türkiye supplied 0.3% of Saudi Arabia's imports of HS 3004: No. 31 of 92 supplying countries.
- Are Türkiye's exports of packaged medicines to Saudi Arabia growing?
- Over the last 12 months (May 2025 to April 2026), US$11.4m of goods under HS 3004 went from Türkiye to Saudi Arabia: +21.8% on the 12 months before.
